Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Relevium Launches LeefyLyfe™ Organic Hemp Products in the US MONTREAL, Canada -- November 20, 2019 -- InvestorsHub NewsWire -- Relevium Technologies Inc. (TSX.V:...
Relevium’s Subsidiary BGX E-Health Secures One Million Dollar Export Contract for the Middle East MONTREAL, Canada -- October 30, 2019 -- InvestorsHub NewsWire -- Relevium...
Relevium Acquires 100% of Late Stage Processing and Medical Sales Applicant Weedsense MONTREAL, Canada -- October 17, 2019 -- InvestorsHub NewsWire -- Relevium Technologies Inc. (TSX.V:...
MONTREAL, Canada -- August 12, 2019 -- InvestorsHub NewsWire -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt:...
Relevium Announces Record Sales From the Bioganix® Brand and Provides CBD Update MONTREAL, Canada -- August 1, 2019 -- InvestorsHub NewsWire -- Relevium Technologies Inc. (TSX.V:...
Relevium Signs Exclusivity Agreement With SOSCannabis.com for Reimbursement for Pediatric PatientsMONTREAL, Canada -- July 10, 2019 -- InvestorsHub NewsWire -- Relevium Technologies Inc. (TSX.V:...
Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali, ColombiaMONTREAL, Canada -- June 13, 2019 -- InvestorsHub NewsWire -- Relevium Technologies Inc. (TSX.V: “RLV”...
Relevium’s Biocannabix Executes LOI to Acquire 30% Interest in Weedsense, a Late Stage Applicant for Standard Processing and Medical Sales License MONTREAL, Canada...
Relevium Acquires Exclusive Licence From California Based Cannakids® MONTREAL, Canada -- May 30, 2019 -- InvestorsHub NewsWire -- Relevium Technologies Inc...
Relevium Announces Private Share Purchase by CEO MONTREAL, Quebec, Canada -- May 21, 2019 -- InvestorsHub NewsWire -- Relevium Technologies Inc. (TSX.V:“RLV”...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 66429 | 1.0E-6 | CS |
| 4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 66429 | 1.0E-6 | CS |
| 12 | -9.0E-6 | -90 | 1.0E-5 | 1.0E-5 | 1.0E-6 | 22176 | 1.0E-6 | CS |
| 26 | 0 | 0 | 1.0E-6 | 1.0E-5 | 1.0E-6 | 13014 | 3.03E-6 | CS |
| 52 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 10431 | 2.609E-5 | CS |
| 156 | -0.012799 | -99.9921875 | 0.0128 | 0.0285 | 1.0E-6 | 56294 | 0.00736282 | CS |
| 260 | -0.028499 | -99.9964912281 | 0.0285 | 0.07 | 1.0E-6 | 56787 | 0.02321375 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
